about
A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivoPyrostegia venusta heptane extract containing saturated aliphatic hydrocarbons induces apoptosis on B16F10-Nex2 melanoma cells and displays antitumor activity in vivo.Antitumor activity of kielmeyera coriacea leaf constituents in experimental melanoma, tested in vitro and in vivo in syngeneic mice.Benzofuroxan derivatives N-Br and N-I induce intrinsic apoptosis in melanoma cells by regulating AKT/BIM signaling and display anti metastatic activity in vivo.A novel cell-penetrating peptide derived from WT1 enhances p53 activity, induces cell senescence and displays antimelanoma activity in xeno- and syngeneic systems.Neolignans isolated from Nectandra leucantha induce apoptosis in melanoma cells by disturbance in mitochondrial integrity and redox homeostasis.Toward chelerythrine optimization: Analogues designed by molecular simplification exhibit selective growth inhibition in non-small-cell lung cancer cells.Apoptotic effect of eugenol envolves G2/M phase abrogation accompanied by mitochondrial damage and clastogenic effect on cancer cell in vitro.Novel capsaicin analogues as potential anticancer agents: synthesis, biological evaluation, and in silico approach.The Ig VH complementarity-determining region 3-containing Rb9 peptide, inhibits melanoma cells migration and invasion by interactions with Hsp90 and an adhesion G-protein coupled receptor.Dillapiole as antileishmanial agent: discovery, cytotoxic activity and preliminary SAR studies of dillapiole analogues.Terpenoids from Leaves of Guarea macrophylla Display In Vitro Cytotoxic Activity and Induce Apoptosis In Melanoma Cells.Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma.
P50
Q30665888-3C2CC6E2-4DFA-4B04-BF56-8333DFB5514DQ33833120-2A6CE01A-9720-4FF2-A110-11D1CA687940Q34424404-4DF77E2F-F16E-4AF7-9B7A-27C3BFE04D4FQ35821825-8F7E2F67-438B-459E-920E-7E528721F47BQ37535193-B19C09DB-9AB9-4AAE-B85D-B152A39EB820Q38704507-20CEDC6B-F031-408C-A031-B592FFA0F40EQ38750093-77027F56-532F-488E-944C-2ED6FE4F7865Q38767891-7A6931EE-9374-4B6D-842E-341B7315D538Q38950465-342DE2E6-B04B-4E2E-B597-27943F811F65Q40523101-021BBBD3-D303-4171-A9C8-7888829E0FBEQ42830446-1CF30213-FF0C-4ABA-A262-4D97FB8C4852Q46386709-98C59FAD-3DFA-4CCA-A571-0F3070186179Q54941924-9C92E8F3-CCFC-48E6-9D64-94846BE414A8
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ricardo A Azevedo
@ast
Ricardo A Azevedo
@en
Ricardo A Azevedo
@es
Ricardo A Azevedo
@nl
type
label
Ricardo A Azevedo
@ast
Ricardo A Azevedo
@en
Ricardo A Azevedo
@es
Ricardo A Azevedo
@nl
prefLabel
Ricardo A Azevedo
@ast
Ricardo A Azevedo
@en
Ricardo A Azevedo
@es
Ricardo A Azevedo
@nl
P106
P108
P1153
55544459700
56057680300
P21
P31
P496
0000-0003-4381-797X